Swoop qualifies for national purchasing in France

TORONTO – Hyperfine, Inc., the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain – the Swoop system – announced that its distribution partner, UpCare Europe SAS (UpCare), has been awarded a national referencing for the Swoop system by UniHA (Union des Hôpitaux pour les Achats), France’s leading public healthcare purchasing cooperative. UpCare is a Canadian company.

UniHA provides a framework that facilitates centralized purchasing for more than 1,500 public hospitals and 130 regional hospital groups across France and French territories with the aim of accelerating the adoption of innovative healthcare technologies.

This selection will enable hospitals to acquire Swoop systems without initiating individual tenders, thus supporting streamlined procurement and removing barriers to adoption. The agreement, effective November 2, 2025, includes an allowance of Swoop system purchases over the next three years, creating a pathway for broader deployment of portable brain imaging technology and marking the first time that portable brain MRI has been included in the UniHA framework.

“This award marks a major milestone in the evolution of patient care,” said Benoit Sai (pictured), co-founder and chief commercial officer of UpCare. “We are proud to partner with Hyperfine to help broaden adoption of the Swoop system throughout France. Ultra-low-field MRI is not merely a technological innovation, it is a transformative response to today’s medical, logistical, and socio-economic challenges. I deeply commend UniHA, Hyperfine, and the French hospital community for their foresight and leadership in advancing imaging access and quality.”

“Being referenced by UniHA is an important recognition of the value of our technology and builds on the momentum we are getting in European markets, following the recent CE marking of our Optive AI software,” said Maria Sainz, president and CEO of Hyperfine, Inc. “France represents one of Europe’s most strategic healthcare markets, and we are proud to partner with UpCare to support French hospitals with advanced imaging solutions that bring care closer to patients.”

For more information about the Swoop system, please visit HyperfineMRI.com.

About the Swoop® Portable MRI Systems
The Swoop Portable MR Imaging Systems are U.S. Food and Drug Administration (FDA) cleared for brain imaging of patients of all ages. They are portable, ultra-low-field magnetic resonance imaging devices for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.

About Hyperfine, Inc.
Hyperfine, Inc. is the groundbreaking health technology company that has redefined brain imaging with the Swoop system – the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visit HyperfineMRI.com.